Active

Formation Bio

General contacts
Investor type

VC

Founded

2016

AUM

-

Location

New York, New York, United States

Investment Ticket

$50-100 m

Investment Stage

Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 30 October, 2026

Profile

Formation Bio is an AI-native pharmaceutical company based in New York City, founded by Benjamine Liu, David Steinberg, and Michael Ehlers. They have a second office in Boston. The team is recognized for merging pharmaceutical and technological expertise to accelerate drug development. What distinguishes Formation Bio is their implementation of an AI-native development platform and clinical operating infrastructure to streamline drug acquisition and development.

Formation Bio invests in clinical-stage pharmaceuticals, focusing on in-licensing and acquiring Phase 1 and Phase 2 drug programs. They prioritize assets aimed at diseases with significant unmet needs and limited active development, targeting clinical milestones within 2-4 years. The company launched the $600 million Drug Development Accelerator Fund to further expand its drug portfolio. Their investments are global in scope as they do not specify a particular regional focus.

Noteworthy investments include developing drug programs targeting various pathologies with unmet clinical needs.

Industry

HealthTech Life Sciences MedTech AI Pharmaceuticals Biotechnology

Formation Bio Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
Formation Bio Drug Development Accelerator Fund
Venture Capital (VC)
Biotechnology
Pharmaceuticals
AI
MedTech
Life Sciences
HealthTech
Late Stage (Series C+)
North America
$50-100 m
$600 M
October 2026

Contacts

Name
Title
Email
Social Networks
avatar
Linhao Zhang Co-Founder
Co-Founder
l•••@•••
LinkedIn
avatar
Ashley Argiras Vice President of Quality
Vice President of Quality
a•••@•••
LinkedIn
Upgrade to see contacts
avatar
2N4REog6VcI1f3HQ 2N4REog6VcI1f3HQ
2N4REog6VcI1f3HQ
[email protected]
linkedin twitter
avatar
2N4REog6VcI1f3HQ 2N4REog6VcI1f3HQ
2N4REog6VcI1f3HQ
[email protected]
linkedin twitter
avatar
2N4REog6VcI1f3HQ 2N4REog6VcI1f3HQ
2N4REog6VcI1f3HQ
[email protected]
linkedin twitter
Investment-team contacts for Formation Bio — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Formation Bio

Formation Bio is a venture capital firm. It backs companies at Series A, Series B and Late Stage (Series C+), writing tickets of $50-100 m.
Formation Bio is located in New York, New York, United States.
Formation Bio was founded in 2016.
Formation Bio invests in companies and startups in HealthTech, Life Sciences, MedTech, AI, Pharmaceuticals, Biotechnology.
Formation Bio invests in companies and startups in North America.
Formation Bio invests in companies and startups at Series A, Series B, Late Stage (Series C+).
Formation Bio usually invests $50-100 m on average.
Formation Bio last fund was created/launched in 2026-10-29
Formation Bio can be reached through its website formation.bio, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Formation Bio — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Formation Bio directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.